Insider Transactions Reported by 53 Insiders of Keenova Therapeutics plc

Location
Dublin 15

Insiders trading volume in the past year

Keenova Therapeutics plc executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
GOLDENTREE ASSET MANAGEMENT LP 10%+ Owner $736,139,041 +$7,562,250 +1% 04 Aug 2025
Silver Point Capital L.P. 10%+ Owner $456,887,866 +$67,917,443 +17% 07 Jan 2026
Alta Fundamental Advisers LLC 10%+ Owner $73,015,988 16 Jun 2023
Sigurdur O. Olafsson President and CEO, Director $2,814,973 25 Feb 2026
Christiana Stamoulis President and CFO $1,582,235 25 Feb 2026
David J. Stetson Director $1,001,497 31 Jul 2025
Wesley Wheeler Director $869,585 31 Jul 2025
Abbas Hussain Director $846,230 31 Jul 2025
Paul Efron Director $781,319 23 Feb 2026
Lisa French EVP & Chief Commercial Officer $744,613 25 Feb 2026
Mark Tyndall EVP & CLO and Corp Sec $724,821 25 Feb 2026
Jon Zinman Director $712,751 23 Feb 2026
Henriette Nielsen EVP & Chief Transformation OFC $668,998 25 Feb 2026
Mark T. Bradley EVP, Chief Integration Officer $371,431 31 Jul 2025
Paul Bisaro Director $370,798 23 Feb 2026
Katina Dorton Director $222,319 23 Feb 2026
Hugh Paul ONeill EVP, Chief Operations Officer $159,928 25 Feb 2026
Sophia D. Langlois Director $68,768 23 Feb 2026
Marc J. Yoskowitz Director $68,076 23 Feb 2026
Tracy Basso Evp & Chro $67,643 25 Feb 2026
Susan Ann Williamson EVP & Chief Compliance Officer $62,799 25 Feb 2026
Cheryl Ann Stouch EVP & Chief Info Officer $54,582 25 Feb 2026
Scott Hirsch Director $39,358 23 Feb 2026
Marek Honczarenko EVP, Chief Scientific Officer 25 Feb 2026
Leslie E. Donato Director 23 Feb 2026
DAVID R. CARLUCCI Director 16 Jun 2022
Frank B. Raciti Controller & CAO 19 Aug 2025
Kassie Harrold EVP & Chief Compliance Officer 01 Jan 2025
David Y. Norton Director 16 Jun 2022
JAMES R. SULAT Director 14 Nov 2023
Steven J. Romano EVP & Chief Sci. Ofcr 16 Jun 2022
Paul Rutherford Carter Director 16 Jun 2022
Daniel Arthur Celentano Director 14 Nov 2023
Riad El-Dada Director 14 Nov 2023
J. MARTIN CARROLL Director 16 Jun 2022
Peter C. Richardson EVP & Chief Scientific Officer 31 Jul 2025
Karen Ling Director 14 Nov 2023
IAN J. WATKINS EVP & Chief Human Resources Officer 16 Jun 2022
WOODROW A. MYERS JR Director 14 Nov 2023
Mark Trudeau President and CEO, Director 16 Jun 2022
JOANN A. REED Director 16 Jun 2022
Casey Mark J EVP & Chief Legal Officer 16 Jun 2022
Bryan M. Reasons Evp & Cfo 31 Jul 2025
Jason Daniel Goodson EVP & Chief Strategy Officer 01 Jan 2025
Hugh M. O'Neill EVP & Chief Comm and Ops Ofcr 16 Jun 2022
Stephen Andrew Welch EVP & Head of Spec Generics 10 Nov 2025
Angus C. Russell Director 16 Jun 2022
Bracebridge Capital, LLC 10%+ Owner 14 Nov 2023
NEAL P. GOLDMAN Director 14 Nov 2023
Susan Silbermann Director 14 Nov 2023
Anne Clem Whitaker Director 16 Jun 2022
DR KNEELAND YOUNGBLOOD Director 16 Jun 2022
Carlos Paya V. Director 16 Jun 2022

Recent Insider Transactions by Companies or Individuals for Keenova Therapeutics plc

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.